Som med anden hiv- medicin kan patienter, der er i behandling med CELSENTRI, få immunreaktiveringssyndrom (infektionslignende symptomer, der skyldes, at immunsystemet genvinder sin funktion) eller osteonekrose (knoglevævsdød).
As with other anti-HIV medicines, patients taking CELSENTRI may be at risk of immune reactivation syndrome (symptoms of infection caused by the recovering immune system) or osteonecrosis (death of bone tissue).